
J.P. Bercu
Advertisement
J.P. Bercu is senior director in nonclinical safety and pathobiology, Gilead Sciences.
Articles by J.P. Bercu

Advertisement
Latest Updated Articles
 Managing the Risk of Nitrosamine Impurities Managing the Risk of Nitrosamine Impurities- Published: March 16th 2021 | Updated: 
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
4
Turning Real-World Data into Actionable Drug Development Insights With AI
5

